Xiangcai Co.,Ltd (China)

The company mainly invest in deep processing of soybean products and health products, biochemical and biological products, traditional Chinese medicine, real estate development and new building materials. The company is based on the life and health industry. 330 million yuan has been invested into soybean intensive processing industries, with a total of four subsidiaries and 50 acres of soybean production bases of modern soybean deep processing chain, manufacturing protein isolate, tissue protein, whey protein, soy fiber, and health food, and it has been a demonstration enterprise of national "Action Plan for soybean" and the leading of Heilongjiang soybean intensive processing enterprises. Three subsidiaries belong to the pharmaceutical industry. It’s dedicated to the development and production of drugs for the treatment of record injury, cardiovascular disease, inhibit tumor growth and treatment of fractures. The real estate belonging to it has five main subsidiaries mainly including Harbin High-Tech Development Co.Ltd Group and Qingdao Port Properties Limited Group, which have cumulatively developed more than a million square meters of all types of building products.